有
http://www.roche.com.sg/portal/eipf/singapore/sg/corporate/roche_in_singapore
貌是生产为主,没多少研发
Roche Technical Operations is a fully-owned Roche subsidiary and was established in Singapore in 2009. With a combined investment of approximately USD500 million, the site is comprised of two state-of-the-art facilities which use two different production technology platforms to manufacture biologic medicines. The facilities occupy approximately 12.6 hectares at the Tuas Biomedical Park.
The Singapore site is an important part of Roche’s global manufacturing network, which includes biotechnology facilities in California (USA), Penzberg (Germany) and Basel (Switzerland). Roche Singapore Technical Operations is expected to be the first company in Singapore to produce licensed biotherapeutics using recombinant DNA technologies.
这个有点意思
是我现在公司的竞争对手加下游企业。
说说我知道的吧:罗氏是个大公司,具体是不是世界500强,我就不确定了,我认为是,这个google比较容易,只知道比我现在公司大很多,估计至少是年收入几百亿美元的大公司。目前主要分成两块,一块是和制药有关,另一块是做诊断试剂,都非常大。本来还有第三块的,是做生科的,前一阵刚和诊断合并了。制药这块在新加坡有生产和研发,生产基地在Tuas,研发中心在SGH。诊断试剂,应该有销售分部。目前趋势是在研发方面,对亚太区投入开始加大,主要是做医学转化研究 Translational Research,之前有个朋友加入了上海的分部。
新加坡这两年对制药行业投入加大,诺华Novartis和安进Amgen已经和EDB达成协议,在2015和2016年会投入生产。加上本地的现有的其他制药企业,到时规模还是有一定基础的,说实话,就是生产基地,成品大部分是送回欧美再包装。总体上新加坡给了很多好处,让这些大公司来新加坡设厂。